Kaleida Capital is a venture capital firm investing in neurotechnology, AI, and cognitive systems redefining the future of human performance.

Founded by Stanford-trained neuroengineer and investor Dr. Ariane Tom, Kaleida Capital was built to identify and back the next generation of cognitive infrastructure — from neural interfaces and brain data platforms to adaptive AI and resilience tools. We invest early, lead with technical rigor, and partner with visionary teams shaping how minds and machines interact.

Kaleida targets early-stage investments in U.S.-based founders with research-driven IP, valuation discipline, and long-term category potential. Portfolio companies include Science, Paradromics, Anthropic, Synchron, Resonant Link Medical, and Manifest Technologies (acquired). 

With experience spanning brain-machine interfaces, computational neuroscience, patent law, and early-stage venture, Kaleida is uniquely positioned to bring deep diligence and domain fluency to an emerging, high-impact frontier.

Kaleida Capital

Org chart

Teams

Offices